Literature DB >> 24928034

Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells.

Adriana Forero1, Kevin D McCormick1, Frank J Jenkins2, Saumendra N Sarkar3.   

Abstract

Primary effusion lymphoma (PEL), associated with the latent infection by KSHV, constitutively expresses interferon-regulatory factor 4 (IRF4). We recently showed that IRF4 differentially regulates expression of cellular interferon-stimulated genes (ISGs) and viral genes (Forero et al., 2013). Here, using inducible IRF4 knockdown, we demonstrate that IRF4 silencing results in enhanced transcription of KSHV replication transactivator RTA. As a result viral transcription is increased leading to virus reactivation. Taken together, our results show that IRF4 helps maintain the balance between latency and KSHV reactivation in PEL cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interferon regulatory factor 4; Kaposi׳s sarcoma-associated herpesvirus; Primary effusion lymphoma

Mesh:

Substances:

Year:  2014        PMID: 24928034      PMCID: PMC4058074          DOI: 10.1016/j.virol.2014.04.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  57 in total

1.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

Authors:  W Zhong; H Wang; B Herndier; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.

Authors:  S Iida; P H Rao; M Butler; P Corradini; M Boccadoro; B Klein; R S Chaganti; R Dalla-Favera
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

3.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

4.  Transcriptional control of adipose lipid handling by IRF4.

Authors:  Jun Eguchi; Xun Wang; Songtao Yu; Erin E Kershaw; Patricia C Chiu; Joanne Dushay; Jennifer L Estall; Ulf Klein; Eleftheria Maratos-Flier; Evan D Rosen
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

5.  An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate.

Authors:  Jianjiang Ye; Duane Shedd; George Miller
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.

Authors:  Ling Wang; Ngoc L Toomey; Luis A Diaz; Gail Walker; Juan C Ramos; Glen N Barber; Shunbin Ning
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

7.  Detection of HHV-8 (human herpesvirus-8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors.

Authors:  L Qu; D J Triulzi; D T Rowe; F J Jenkins
Journal:  Vox Sang       Date:  2010-09-02       Impact factor: 2.144

8.  Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.

Authors:  Faye Gould; Sally M Harrison; Eric W Hewitt; Adrian Whitehouse
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

9.  The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

Authors:  Shuvomoy Banerjee; Jie Lu; Qiliang Cai; Abhik Saha; Hem Chandra Jha; Richard Kuo Dzeng; Erle S Robertson
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

10.  Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines.

Authors:  Barbara A Scholz; Marie L Harth-Hertle; Georg Malterer; Juergen Haas; Joachim Ellwart; Thomas F Schulz; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

View more
  7 in total

1.  Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Kathleen M Wyvill; Karen Aleman; Cody J Peer; Margaret Bevans; Irini Sereti; Frank Maldarelli; Denise Whitby; Vickie Marshall; Priscila H Goncalves; Vikram Khetani; William D Figg; Seth M Steinberg; Jerome B Zeldis; Robert Yarchoan
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

2.  Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs.

Authors:  Angela Park; Soohwan Oh; Kyle L Jung; Un Yung Choi; Hye-Ra Lee; Michael G Rosenfeld; Jae U Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

3.  Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.

Authors:  Dong-Wen Lv; Kun Zhang; Renfeng Li
Journal:  PLoS Pathog       Date:  2018-01-22       Impact factor: 6.823

4.  Impact of HVT Vaccination on Splenic miRNA Expression in Marek's Disease Virus Infections.

Authors:  Julie A Hicks; Hsiao-Ching Liu
Journal:  Genes (Basel)       Date:  2019-02-05       Impact factor: 4.096

5.  KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth.

Authors:  Michiko Shimoda; Yuanzhi Lyu; Kang-Hsin Wang; Ashish Kumar; Hiroki Miura; Joshua F Meckler; Ryan R Davis; Chanikarn Chantarasrivong; Chie Izumiya; Clifford G Tepper; Ken-Ichi Nakajima; Joseph Tuscano; Gustavo Barisone; Yoshihiro Izumiya
Journal:  Commun Biol       Date:  2021-12-02

6.  Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.

Authors:  Xiang Luo; Rong Huang; Hongru Sun; Yupeng Liu; Haoran Bi; Jing Li; Hongyuan Yu; Jiamei Sun; Shangqun Lin; Binbin Cui; Yashuang Zhao
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

7.  Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.

Authors:  Mark Manzano; Thomas Günther; Hyunwoo Ju; John Nicholas; Elizabeth T Bartom; Adam Grundhoff; Eva Gottwein
Journal:  mBio       Date:  2020-08-25       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.